Reaktion #610581

ord-d2976771ee2b4816bfcce4394467cbca

Lösungsmittel

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    workup.STIRRINGthe resulting mixture was stirred at room temperature for 3 hours
  2. 2
    Waschenwashed with saturated aqueous NaHCO3 solution
  3. 3
    SonstigeThe organic layer was separated
  4. 4
    Sonstigedried
  5. 5
    Einengenconcentrated
  6. 6
    Sonstigepurified (Interchim reverse phase chromatography column; 5-70% MeCN in water with 0.5% TFA)
  7. 7
    workup.STIRRINGthe resulting mixture was stirred at room temperature for 30 minutes
  8. 8
    SonstigeThe solvent was removed
  9. 9
    Sonstigeazeotroped with toluene (2×)

Vorschrift

(2S,4R)-5-Biphenyl-4-yl-4-t-butoxycarbonylamino-2-hydroxymethyl-2-methyl-pentanoic acid (125 mg, 302 μmol), HOBt (240 mg, 1.8 mmol), and EDCI (320 μL, 1.8 mmol) were dissolved in DCM and stirred for 2 minutes. N-(2-Hydroxyethyl)piperidine (401 μL, 3.0 mmol) was added and the resulting mixture was stirred at room temperature for 3 hours. The mixture was diluted with DCM and washed with saturated aqueous NaHCO3 solution. The organic layer was separated, dried, concentrated, then purified (Interchim reverse phase chromatography column; 5-70% MeCN in water with 0.5% TFA). The purified material was combined with MeCN (3.0 mL, 58 mmol) and 4 M HCl in dioxane (0.3 mL, 1.2 mmol) and the resulting mixture was stirred at room temperature for 30 minutes. The solvent was removed and azeotroped with toluene (2×) to yield (2S,4R)-4-amino-5-biphenyl-4-yl-2-hydroxymethyl-2-methyl-pentanoic acid 2-piperidin-1-yl-ethyl ester.

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US09334245B2uspto-grants-2016_05